The Pennsylvania Record reported today that Ross Feller Casey has filed the first personal injury lawsuit involving a testosterone-containing drug in Philadelphia, and one of only a very few brought to date nationwide.

The legal journal reported that the case involves an Alabama man, Robert Hoehl, who suffered a stroke while taking Testim, one of many so-called "Low T" therapy drugs on the market. Among other things, the suit says that Testim caused the stroke and that the maker and co-promoter of the drug -- Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC, respectively -- used deceptive marketing techniques to promote the drug.

The suit comes on the heels of the FDA's decision in January to review all Low T drugs based on two recent studies that demonstrated they greatly increased the risks of serious cardiovascular events, including heart attacks and strokes, in men.

Read the story

Ross Feller Casey is actively investigating other serious injuries reported to the firm by man nationwide who have taken testosterone replacement therapies. The testosterone lawyers at Ross Feller Casey expect to file additional testosterone lawsuits on behalf of those men and their families soon.

For more information, go to

Disclaimer: Ross Feller Casey, LLP provides legal advice only after an attorney-client relationship is formed. Our website is an introduction to the firm and does not create a relationship between our attorneys and clients. An attorney-client relationship is formed only after a written agreement is signed by the client and the firm. Because every case is unique, the description of awards and summary of cases successfully handled are not intended to imply or guarantee that same success in other cases. Ross Feller Casey, LLP represents catastrophically injured persons and their families in injury and wrongful death cases, providing legal representation in Pennsylvania and New Jersey.